» Articles » PMID: 15480433

Frequent Hypermethylation of RASSF1A in Early Flat-type Colorectal Tumors

Overview
Journal Oncogene
Date 2004 Oct 14
PMID 15480433
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Flat colorectal tumors, characterized by high-grade dysplasia from early small flat mucosal lesions, exhibit a relatively aggressive clinical behavior and are known for their infrequent K-ras mutations. In this study, we investigated the methylation status of the RASSF1A promoter in association with 3p LOH and K-ras mutations in 48 flat colorectal tumors (39 early carcinomas and nine intramucosal high-grade dysplasias). RASSF1A hypermethylation was detected in 39 of 48 (81.3%) tumors and RASSF1A methylation was also detected in 19 of 39 (49%) normal colonic mucosal tissues. 3p21.3 LOH was detected in 20 of 42 (47.6%) cases, but RASSF1 methylation was detected in cases with LOH (14 cases) and retention of 3p21.3 (20 cases). K-ras mutations were detected in seven of 48 (14.6%) tumors and the concordant occurrence of K-ras mutation and RASSF1A methylation was detected in three of 48 cases (6.3%). Overall, there was a statistically significant mutually exclusive relationship between K-ras mutations and RASSF1A methylation. In conclusion, promoter hypermethylation of RASSF1A is a frequent event and may start early in the background normal mucosa in this tumor type. An alternative cascade of abnormalities in RAS transduction pathways may be responsible for the flat morphology and aggressive nature of flat colorectal neoplasms.

Citing Articles

Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction.

Nassar F, Msheik Z, Nasr R, Temraz S Clin Epigenetics. 2021; 13(1):111.

PMID: 34001239 PMC: 8130320. DOI: 10.1186/s13148-021-01095-5.


Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis.

Tabibzadeh A, Safarnezhad Tameshkel F, Moradi Y, Soltani S, Moradi-Lakeh M, Ashrafi G Sci Rep. 2020; 10(1):18713.

PMID: 33127962 PMC: 7599243. DOI: 10.1038/s41598-020-73770-1.


Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal Intestine.

Nterma P, Panopoulou E, Papadaki-Petrou E, Assimakopoulou M Pathol Oncol Res. 2019; 26(1):567-574.

PMID: 30604274 DOI: 10.1007/s12253-018-00575-z.


A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.

Freitas M, Ferreira F, Carvalho S, Silva F, Lopes P, Antunes L J Transl Med. 2018; 16(1):45.

PMID: 29486770 PMC: 6389195. DOI: 10.1186/s12967-018-1415-9.


β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients.

Schirosi L, Mazzotta A, Opinto G, Pinto R, Graziano G, Tommasi S Oncotarget. 2016; 7(42):67841-67850.

PMID: 27765918 PMC: 5356523. DOI: 10.18632/oncotarget.12280.